Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:33 pm Sale |
2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Cormorant Asset Management LP | 6,411,355 7.760% |
-475,000 (-6.90%) |
Filing History |
| 2021-02-10 4:31 pm Purchase |
2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Sommadossi Jean-Pierre | 6,801,664 8.200% |
6,801,664 (New Position) |
Filing History |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | Atea Pharmaceuticals, Inc. AVIR |
FMR CORP | 6,447,691 7.804% |
6,447,691 (New Position) |
Filing History |
| 2020-11-13 4:01 pm Purchase |
2020-11-03 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Cormorant Asset Management LP | 6,886,355 8.340% |
6,886,355 (New Position) |
Filing History |
| 2020-11-12 4:15 pm Purchase |
2020-11-03 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Bain Capital Life Sciences Fund II, L.P. | 4,783,102 5.800% |
4,783,102 (New Position) |
Filing History |